<code id='A55ABEFFCD'></code><style id='A55ABEFFCD'></style>
    • <acronym id='A55ABEFFCD'></acronym>
      <center id='A55ABEFFCD'><center id='A55ABEFFCD'><tfoot id='A55ABEFFCD'></tfoot></center><abbr id='A55ABEFFCD'><dir id='A55ABEFFCD'><tfoot id='A55ABEFFCD'></tfoot><noframes id='A55ABEFFCD'>

    • <optgroup id='A55ABEFFCD'><strike id='A55ABEFFCD'><sup id='A55ABEFFCD'></sup></strike><code id='A55ABEFFCD'></code></optgroup>
        1. <b id='A55ABEFFCD'><label id='A55ABEFFCD'><select id='A55ABEFFCD'><dt id='A55ABEFFCD'><span id='A55ABEFFCD'></span></dt></select></label></b><u id='A55ABEFFCD'></u>
          <i id='A55ABEFFCD'><strike id='A55ABEFFCD'><tt id='A55ABEFFCD'><pre id='A55ABEFFCD'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:7166
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech
          Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

          TomDiLengeofFlagshipPioneering(left)withU.S.CongressmanRajaKrishnamoorthiofIllinoisata"techfair"desi

          read more
          Wildfire smoke exposes gaps in outdoor worker protections
          Wildfire smoke exposes gaps in outdoor worker protections

          ApersonwaitingforthesubwaywearsafilteredmaskassmokyhazefromwildfiresinCanadablanketsaneighborhoodinN

          read more

          A new drug could help frostbite victims avoid its ravages

          JonCherry/GettyImagesTwodaysafterhisrighthandfroze,HartBeznerrealizedforthefirsttimethathemightlosei